(NASDAQ: DCTH) Delcath Systems's forecast annual revenue growth rate of 21.52% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.57%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.97%.
Delcath Systems's revenue in 2026 is $90,441,000.On average, 9 Wall Street analysts forecast DCTH's revenue for 2026 to be $3,657,223,283, with the lowest DCTH revenue forecast at $3,444,017,591, and the highest DCTH revenue forecast at $3,878,161,824. On average, 9 Wall Street analysts forecast DCTH's revenue for 2027 to be $4,719,454,361, with the lowest DCTH revenue forecast at $4,097,029,066, and the highest DCTH revenue forecast at $5,473,407,132.
In 2028, DCTH is forecast to generate $5,567,306,012 in revenue, with the lowest revenue forecast at $4,641,780,656 and the highest revenue forecast at $6,153,138,361.